Identification of patients who will benefit is important after FOURIER

Media formats available:

E-counselling improves adherence in hypertensives
E-counselling improves adherence in hypertensives
ACC.17
E-counselling improves adherence in hypertensives
- Dr. Rob Nolan
The longer you treat, the better the benefit: lessons from PCSK9 inhibitors trials
The longer you treat, the better the benefit: lessons from PCSK9 inhibitors trials
ACC.17
The longer you treat, the better the benefit: lessons from PCSK9 inhibitors trials
- Prof. Stephen J. Nicholls
Initiating digoxin in AF patients associated with early hazard of sudden death
Initiating digoxin in AF patients associated with early hazard of sudden death
ACC.17
Initiating digoxin in AF patients associated with early hazard of sudden death
- Dr. Renato Lopes
PCSK9 outcome trials: The results put into perspective of other clinical developments
PCSK9 outcome trials: The results put into perspective of other clinical developments
ACC.17
PCSK9 outcome trials: The results put into perspective of other clinical developments
- Prof. Peter Sever

PACE-CME